Literature DB >> 28803755

Communicating complex genomic information: A counselling approach derived from research experience with Autism Spectrum Disorder.

Ny Hoang1, Cheryl Cytrynbaum2, Stephen W Scherer3.   

Abstract

Individuals with Autism Spectrum Disorder (ASD) share characteristics (impairments in socialization and communication, and repetitive interests and behaviour), but differ in their developmental course, pattern of symptoms, and cognitive and language abilities. The development of standardized phenotyping has revealed ASD to clinically be vastly heterogeneous, ranging from milder presentations to more severe forms associated with profound intellectual disability. Some 100 genes have now been implicated in the etiology of ASD, and advances in genome-wide testing continue to yield new data at an unprecedented rate. As the translation of this data is incorporated into clinical care, genetic professionals/counsellors, as well as other health care providers, will benefit from guidelines and tools to effectively communicate such genomic information. Here, we present a model to facilitate communication regarding the complexities of ASD, where clinical and genetic heterogeneity, as well as overlapping neurological conditions are inherent. We outline an approach for counselling families about their genomic results grounded in our direct experience from counselling families participating in an ASD research study, and supported by rationale from the literature.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autism Spectrum Disorder; Counselling model; Genetic counselling; Genetics of Autism Spectrum Disorder

Mesh:

Year:  2017        PMID: 28803755     DOI: 10.1016/j.pec.2017.07.029

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  8 in total

1.  CNTN5-/+or EHMT2-/+human iPSC-derived neurons from individuals with autism develop hyperactive neuronal networks.

Authors:  Eric Deneault; Muhammad Faheem; Sean H White; Deivid C Rodrigues; Song Sun; Wei Wei; Alina Piekna; Tadeo Thompson; Jennifer L Howe; Leon Chalil; Vickie Kwan; Susan Walker; Peter Pasceri; Frederick P Roth; Ryan Kc Yuen; Karun K Singh; James Ellis; Stephen W Scherer
Journal:  Elife       Date:  2019-02-12       Impact factor: 8.140

2.  Families with complex needs: an inside perspective from young people, their carers, and healthcare providers.

Authors:  Mădălina Radu; Ramona Moldovan; Adriana Băban
Journal:  J Community Genet       Date:  2022-03-18

3.  Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants.

Authors:  M T Siu; D T Butcher; A L Turinsky; C Cytrynbaum; D J Stavropoulos; S Walker; O Caluseriu; M Carter; Y Lou; R Nicolson; S Georgiades; P Szatmari; E Anagnostou; S W Scherer; S Choufani; M Brudno; R Weksberg
Journal:  Clin Epigenetics       Date:  2019-07-16       Impact factor: 6.551

4.  Genetics and genetic counseling in psychiatry: Results from an opinion survey of professionals and users.

Authors:  Lourdes Martorell; Annabel Sanfeliu; Ana Blázquez; Elia Lojo; Maria José Cortés; Joan de Pablo; Elisabet Vilella
Journal:  Mol Genet Genomic Med       Date:  2019-06-29       Impact factor: 2.183

5.  Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism.

Authors:  Thomas W Frazier; Ritika Jaini; Robyn M Busch; Matthew Wolf; Tammy Sadler; Patricia Klaas; Antonio Y Hardan; Julian A Martinez-Agosto; Mustafa Sahin; Charis Eng
Journal:  Mol Autism       Date:  2021-01-28       Impact factor: 7.509

6.  An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder.

Authors:  Cinzia Cameli; Marta Viggiano; Magali J Rochat; Alessandra Maresca; Leonardo Caporali; Claudio Fiorini; Flavia Palombo; Pamela Magini; Renée C Duardo; Fabiola Ceroni; Maria C Scaduto; Annio Posar; Marco Seri; Valerio Carelli; Paola Visconti; Elena Bacchelli; Elena Maestrini
Journal:  J Cell Mol Med       Date:  2021-01-21       Impact factor: 5.310

7.  Access, utilization, and awareness for clinical genetic testing in autism spectrum disorder in Sweden: A survey study.

Authors:  Anna Hellquist; Kristiina Tammimies
Journal:  Autism       Date:  2021-12-28

8.  Heterogeneity in clinical sequencing tests marketed for autism spectrum disorders.

Authors:  Ny Hoang; Janet A Buchanan; Stephen W Scherer
Journal:  NPJ Genom Med       Date:  2018-09-19       Impact factor: 8.617

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.